Your browser doesn't support javascript.
loading
Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review. Ivermectin's suggested benefits are mainly based on potentially biased results.
Izcovich, Ariel; Peiris, Sasha; Ragusa, Martín; Tortosa, Fernando; Rada, Gabriel; Aldighieri, Sylvain; Reveiz, Ludovic.
Affiliation
  • Izcovich A; Incident Management System for the Covid-19 Response. Pan American Health Organization, 525 23rd St, Northwest Washington, DC 20037-2895. Electronic address: ariel.izcovich@gmail.com.
  • Peiris S; Incident Management System for the Covid-19 Response. Pan American Health Organization, 525 23rd St, Northwest Washington, DC 20037-2895.
  • Ragusa M; Evidence and Intelligence for Action in Health Department. Pan American Health Organization, Northwest Washington, DC.
  • Tortosa F; Evidence and Intelligence for Action in Health Department. Pan American Health Organization, Northwest Washington, DC.
  • Rada G; Fundación Epistemonikos, Providencia, SAN, Chile.
  • Aldighieri S; Incident Management System for the Covid-19 Response. Pan American Health Organization, 525 23rd St, Northwest Washington, DC 20037-2895.
  • Reveiz L; Incident Management System for the Covid-19 Response. Pan American Health Organization, 525 23rd St, Northwest Washington, DC 20037-2895.
J Clin Epidemiol ; 144: 43-55, 2022 04.
Article in En | MEDLINE | ID: mdl-34933115

Full text: 1 Database: MEDLINE Main subject: Ivermectin / COVID-19 Drug Treatment Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: J Clin Epidemiol Journal subject: EPIDEMIOLOGIA Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Ivermectin / COVID-19 Drug Treatment Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: J Clin Epidemiol Journal subject: EPIDEMIOLOGIA Year: 2022 Type: Article